Risk factors of second-line antirheumatic drugs in rheumatoid arthritis.
Wijnands
M J
MJ
Department of Rheumatology, University Hospital Nijmegen, The Netherlands.
van Riel
P L
PL
Gribnau
F W
FW
van de Putte
L B
LB
D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D012907:Smoking / Q000009:adverse effects
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D006680:HLA Antigens